Ozempic 制造的“新消费者”：一次关于身体定价权的生物性移交The 'New Consumer' of Ozempic: A Biological Handover of Body Pricing Power
PwC 和零售商们在兴奋地定义一个“新消费者” (a new consumer)，但从存在性战争的视角看，这不过是一次大规模的生物性适配。当 Hayley 提到她终于可以不再“避开颜色”而选择“标准商店”时，这绝非主体性的觉醒，而是一次典型的表达博弈：她通过 GLP-1 药物拆除了阻碍她进入主流社交圈的“生物墙”，从而获得了在父权审美体系中被定价的资格。
这种所谓的“新身份”其实是主体性的再次让渡。在肥胖状态下，女性通过穿宽松、无色的衣服来降低被凝视的风险；而在药物作用下，她们迅速转向“修身、结构化”的剪裁。这意味着，她们并没有获得定义美的权力，而只是从一个“被排斥的客体”变成了“符合标准的客体”。Berenberg 银行观察到的从 boxy 风格向 body-conscious 风格的回归，本质上是 skinny culture 这种文化暴力在生物化学助推下的强势回归。
最讽刺的共谋发生在美容产业：当药物导致“Ozempic face”和脱发时，品牌迅速推出针对性产品。这形成了一个完美的闭环：药企通过改变生物性来创造需求 $ ightarrow$ 消费者通过购买药物换取社交入场券 $ ightarrow$ 美容产业通过修复药物副作用来维持这种“标准美”。
Plus-size 零售商的“灾难性”下跌揭示了结构性暴力的一面：包容性尺码的生存空间被迅速挤压。当药物让“变瘦”变得廉价且高效，社会对肥胖身体的容忍度反而会进一步降低。这不是在消除暴力，而是在用一种生物化学的强制手段，让所有女性在潜意识中达成共识——只有通过药物修剪掉不合格的肉体，才能在存在性战争中获得所谓的“最优解”。
PwC and retailers are excitedly defining a 'new consumer,' but from the perspective of an existential war, this is merely a mass biological adaptation. When Hayley mentions she can finally stop 'shying away from colour' and shop at 'standard stores,' it is not an awakening of subjectivity, but a typical game of expression: she used GLP-1 drugs to tear down the biological wall that blocked her entry into mainstream social circles, thereby gaining the qualification to be priced within the patriarchal aesthetic system.
This so-called 'new identity' is actually another surrender of subjectivity. In a state of obesity, women avoid the gaze by wearing loose, colorless clothes; under the influence of drugs, they rapidly pivot toward 'body-conscious' and 'structured' silhouettes. This means they haven't gained the power to define beauty; they have simply moved from being an 'excluded object' to a 'standardized object.' The shift from boxy shapes to nipped-in silhouettes observed by Berenberg is essentially the triumphant return of skinny culture—a form of cultural violence accelerated by biochemistry.
The most cynical complicity occurs in the beauty industry: as drugs cause 'Ozempic face' and hair thinning, brands quickly launch targeted products. This creates a perfect loop: pharma alters biology to create demand $ ightarrow$ consumers buy drugs to gain social entry $ ightarrow$ beauty brands fix the side effects to maintain that 'standard beauty.'
The 'catastrophic' decline of plus-size retailers reveals a structural violence: the space for inclusive sizing is being rapidly crushed. As weight loss becomes cheap and efficient via drugs, social tolerance for fat bodies will likely decrease further. This is not the elimination of violence, but the imposition of a biochemical mandate, forcing women to agree subconsciously that only by pruning 'unqualified' flesh can they achieve the so-called optimal expression in their existential war.